“Pathways to Precision Care” is the theme for ANZGOG’s ASM 2022. We will explore the pathways from translational research into clinical trials; review how molecular profiles and genetics are shaping the management of ovarian and endometrial cancer; and how we can optimise patient care.
The ANZGOG ASM 2022 will be delivered in a hybrid format and registrations are available for in person and online attendance. The ASM 2022 will be held from Wednesday 23 March – Saturday 26 March, at the Crown Promenade Melbourne. If at any time you are unable to travel to Melbourne and attend in person, the ANZGOG registration team will happily convert your registration to an online registration.
As we navigate this difficult time, we will be monitoring the situation closely and keep you posted with updates or changes should the ASM be impacted due to the pandemic.
We are pleased to announce our distinguished international speakers:
(Gynaecological Oncologist, Policlinico A. Gemelli Foundation, Rome, Italy)
(Radiation Oncologist, University of Utah, Salt Lake City, USA)
(Medical Oncologist, Vall d’Hebron Institute of Oncology, Barcelona, Spain)
ANZGOG’s Annual Scientific Meeting brings together national and international experts in gynaecological medicine, radiation and surgical oncology, pathology, basic scientists, translational and quality of life researchers, study coordinators and nurses, as well as our partners in the pharmaceutical industry.
The meeting enables attendees to learn about the latest developments in gynaecological cancer and provides education and capacity building opportunities amongst members and industry personnel. The Pure Science Symposium is the forum for scientists to learn about the cutting edge research and developments in the pre-clinical and translational space. The meeting is attended by over 300 delegates (close to a third of ANZGOG membership).
We would like to thank members of the ANZGOG Scientific Meeting Program Committee for helping to organise the Annual Scientific Meeting 2022. In particular, the Deputy Chair of the 2022 ASM Program Committee Associate Professor Yoland Antill who will welcome delegates to Melbourne.
Dr Michelle Harrison
Assoc Professor Philip Beale
Sponsorship & Exhibition Prospectus
Early Bird Registration Closes
13 February 2022
ANZGOG ASM 2022 Program Steering Committee
Dr Michelle Harrison – Chair
Associate Professor Yoland Antill – Deputy Chair
Associate Professor Philip Beale – Chair, ANZGOG
Associate Professor Nikola Bowden
Dr Michael Burling
Dr David Chang
Dr Jennifer Chard
Dr Paul Cohen
Associate Professor Caroline Ford
Dr Pearly Khaw
Ms Wanda Lawson
Dr Yeh Chen Lee
Professor Deborah Marsh
Ms Anne Mellon
Dr Bryony Simcock
Dr Michelle Wilson
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for treatment of diseases in three therapy areas – Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, visit www.astrazeneca.com and www.astrazeneca.com.au.